Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Celiac disease serology and gut microbiome following proton pump inhibitor treatment.

Medicine - 28 Aug 2020

Jang Sophie, Lebwohl Benjamin, Abrams Julian A, Green Peter H R, Freedberg Daniel E, Alaedini Armin

Abstract excerpt

BACKGROUND: Celiac disease is an autoimmune enteropathy characterized by an aberrant immune response to ingested gluten in genetically predisposed individuals. Studies have pointed to a rising prevalence of celiac disease in recent decades. Changes in diet and use of medication that may impact the gut microbiome have been suggested as potential contributors. Exposure to proton pump inhibitors (PPIs) was recently...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Actinomycetales
Share to Celiac Disease
Share to Gastrointestinal Tract

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutens

Share to Omeprazole

Share to Protein Glutamine gamma Glutamyltransferase 2

Share to Proton Pump Inhibitors

Share to Transglutaminases

Source

Open in PubMed Open full text

Identifiers

PMID: 32871870
DOI: 10.1097/MD.0000000000021488
PMCID: PMC7458245

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Celiac disease serology and gut microbiome following proton pump inhibitor treatment.PMID 32871870Read ↗

The Role of Intestinal Microbiota in Celiac Disease and Further Therapeutic PerspectivesSemantic proximity Read ↗

A review of the long-term use of proton pump inhibitors and risk of celiac disease in the context of HLA-DQ2 and HLA-DQ8 genetic predisposition.Semantic proximity Read ↗

Interaction between Gut Microbiota and Celiac Disease: From Pathogenesis to TreatmentSemantic proximity Read ↗

Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of AutoimmunitySemantic proximity Read ↗

Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment.Semantic proximity Read ↗

Microbiome and Gluten.Semantic proximity Read ↗

Recent advances in pediatric celiac disease.Semantic proximity Read ↗

Gut Microbiota in Celiac Disease: Is There Any Role for Probiotics?Semantic proximity Read ↗

Celiac Disease Genomic, Environmental, Microbiome, and Metabolomic (CDGEMM) Study Design: Approach to the Future of Personalized Prevention of Celiac Disease.Semantic proximity Read ↗

Diagnosing coeliac disease and the potential for serological markers.Semantic proximity Read ↗

Efficacy of probiotics supplementation in amelioration of celiac disease symptoms and enhancement of immune systemSemantic proximity Read ↗

Salivary and fecal microbiota and metabolome of celiac children under gluten-free dietSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.